These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33041289)

  • 1. High Prevalence of Left Ventricular Non-Compaction and Its Effect on Chemotherapy-Related Cardiac Dysfunction in Patients With Hematological Diseases.
    Hirano M; Kimura K; Ishigaki T; Nojima M; Daimon M; Morita H; Takenaka K; Xu B; Sawada N; Hirokawa M; Komuro I; Morisaki T; Yotsuyanagi H; Kawamata T; Yokoyama K; Konuma T; Kato S; Yasui H; Nagamura-Inoue T; Uchimaru K; Takahashi S; Imai Y; Tojo A
    Circ J; 2020 Oct; 84(11):1957-1964. PubMed ID: 33041289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between regional left ventricular dysfunction and cancer-therapy-related cardiac dysfunction.
    Saijo Y; Kusunose K; Okushi Y; Yamada H; Toba H; Sata M
    Heart; 2020 Nov; 106(22):1752-1758. PubMed ID: 32209616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer: Comparison With Echocardiography.
    Houbois CP; Nolan M; Somerset E; Shalmon T; Esmaeilzadeh M; Lamacie MM; Amir E; Brezden-Masley C; Koch CA; Thevakumaran Y; Yan AT; Marwick TH; Wintersperger BJ; Thavendiranathan P
    JACC Cardiovasc Imaging; 2021 May; 14(5):962-974. PubMed ID: 33248962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of reduced global longitudinal strain with cancer therapy-related cardiac dysfunction among patients receiving cancer therapy.
    Laufer-Perl M; Arnold JH; Mor L; Amrami N; Derakhshesh M; Moshkovits Y; Sadeh B; Arbel Y; Topilsky Y; Rozenbaum Z
    Clin Res Cardiol; 2020 Feb; 109(2):255-262. PubMed ID: 31214777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of systolic and diastolic criteria for isolated LV noncompaction in CMR.
    Stacey RB; Andersen MM; St Clair M; Hundley WG; Thohan V
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):931-40. PubMed ID: 23769489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.
    Negishi T; Thavendiranathan P; Negishi K; Marwick TH;
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1098-1105. PubMed ID: 29909105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic and clinical markers of left ventricular ejection fraction and moderate or greater systolic dysfunction in left ventricular noncompaction cardiomyopathy.
    Arenas IA; Mihos CG; DeFaria Yeh D; Yucel E; Elmahdy HM; Santana O
    Echocardiography; 2018 Jul; 35(7):941-948. PubMed ID: 29577407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-analysis.
    Oikonomou EK; Kokkinidis DG; Kampaktsis PN; Amir EA; Marwick TH; Gupta D; Thavendiranathan P
    JAMA Cardiol; 2019 Oct; 4(10):1007-1018. PubMed ID: 31433450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between clinical risk factors and left ventricular function in patients with breast cancer following chemotherapy.
    Yamashita K; Tanaka H; Hatazawa K; Tanaka Y; Sumimoto K; Shono A; Suzuki M; Yokota S; Suto M; Mukai J; Takada H; Matsumoto K; Minami H; Hirata KI
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):197-205. PubMed ID: 32860123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The planimetric Grothoff's criteria by cardiac magnetic resonance can improve the specificity of left ventricular non-compaction diagnosis in thalassemia intermedia.
    Macaione F; Meloni A; Positano V; Pistoia L; Barison A; Di Lisi D; Spasiano A; Campisi S; Spiga A; Righi R; Novo G; Novo S; Pepe A
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1105-1112. PubMed ID: 32086653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity.
    Ohtani K; Fujino T; Ide T; Funakoshi K; Sakamoto I; Hiasa KI; Higo T; Kamezaki K; Akashi K; Tsutsui H
    Clin Res Cardiol; 2019 Jun; 108(6):600-611. PubMed ID: 30367208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
    J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated left ventricular non-compaction in adults: clinical and echocardiographic features in 105 patients. Results from a French registry.
    Habib G; Charron P; Eicher JC; Giorgi R; Donal E; Laperche T; Boulmier D; Pascal C; Logeart D; Jondeau G; Cohen-Solal A;
    Eur J Heart Fail; 2011 Feb; 13(2):177-85. PubMed ID: 21193437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic measures associated with the presence of left ventricular thrombus in patients with chemotherapy-related cardiac dysfunction.
    Kitkungvan D; Yusuf SW; Moudgil R; Palaskas N; Guindani M; Juhee S; Hassan S; Sanchez L; Banchs J
    Echocardiography; 2018 Oct; 35(10):1512-1518. PubMed ID: 30005128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity.
    Nucifora G; Aquaro GD; Pingitore A; Masci PG; Lombardi M
    Eur J Heart Fail; 2011 Feb; 13(2):170-6. PubMed ID: 21208941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction.
    Grigoratos C; Barison A; Ivanov A; Andreini D; Amzulescu MS; Mazurkiewicz L; De Luca A; Grzybowski J; Masci PG; Marczak M; Heitner JF; Schwitter J; Gerber BL; Emdin M; Aquaro GD
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2141-2151. PubMed ID: 30878415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy.
    Thavendiranathan P; Negishi T; Somerset E; Negishi K; Penicka M; Lemieux J; Aakhus S; Miyazaki S; Shirazi M; Galderisi M; Marwick TH;
    J Am Coll Cardiol; 2021 Feb; 77(4):392-401. PubMed ID: 33220426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left ventricular ejection fraction and myocardial strain imaging over 12 months.
    Stoodley PW; Richards DA; Boyd A; Hui R; Harnett PR; Meikle SR; Byth K; Stuart K; Clarke JL; Thomas L
    Eur J Cancer; 2013 Nov; 49(16):3396-403. PubMed ID: 23937961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.